๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS ยท Real-Time Price ยท USD
13.66
-0.50 (-3.53%)
At close: Nov 20, 2026, 4:00 PM EST
13.70
+0.04 (0.29%)
After-hours: Nov 20, 2026, 7:30 PM EST

Mineralys Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-389.75-170.6-192.4-84.66-31.48-18.73
Net Income
-369.97-154.65-177.81-71.9-29.8-19.41
Earnings Per Share
-4.38-2.29-3.66-1.99-5.77-3.89
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
624.67656.64198.19236.57110.1110.61
Total Debt
98.27-----
Net Cash (Debt)
526.4656.64198.19236.57110.1110.61
Net Cash Growth
-11.33%231.32%-16.22%114.85%937.60%-
Net Cash Per Share
6.239.714.086.5421.312.13

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-153.01-142.42-166.31-81.17-29.22-14.56
Capital Expenditures
-0.02-0.02-0.1---
Free Cash Flow
-153.03-142.43-166.41-81.17-29.22-14.56
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.